NowRx Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
79
- Latest Deal Type
-
2ndary - Private
- Investors
-
12
NowRx General Information
Description
Operator of an on-demand digital pharmacy intended to offer same-day prescription and delivery of medicines. The company's pharmacy delivery system uses a comprehensive array of communication devices including mobile applications, text, email, phone, fax, and voice-activated virtual personal assistants, end-to-end robotic dispensing, and a logistics platform, enabling users to avoid the need to visit a pharmacy and instead purchase them from the comfort of their homes.
Contact Information
Website
www.nowrx.comCorporate Office
- 30025 Alicia Parkway
- Suite 674
- Laguna Niguel, CA 92677
- United States
Corporate Office
- 30025 Alicia Parkway
- Suite 674
- Laguna Niguel, CA 92677
- United States
NowRx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 8. Equity Crowdfunding | 10-Aug-2021 | Completed | Generating Revenue | |||
| 7. Debt - PPP | 14-Apr-2020 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series B) | 08-Feb-2020 | Completed | Generating Revenue | |||
| 5. Equity Crowdfunding | 07-Nov-2018 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 16-Oct-2018 | Completed | Generating Revenue | |||
| 3. Seed Round | 21-Mar-2017 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 21-Mar-2017 | $2.3M | Completed | Generating Revenue | ||
| 1. Angel (individual) | 13-Jan-2017 | $2.3M | $2.3M | Completed | Generating Revenue |
NowRx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 8,841,611 | $0.000010 | $2 | $2 | 1x | $2 | 30.52% |
NowRx Comparisons
Industry
Financing
Details
NowRx Competitors (4)
One of NowRx’s 4 competitors is PillPack, a Formerly VC-backed company based in Manchester, NH.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| PillPack | Formerly VC-backed | Manchester, NH | ||||
| Practo | Venture Capital-Backed | Bengaluru, India | ||||
| Alto Pharmacy | Formerly VC-backed | San Francisco, CA | ||||
| Blink Health | Private Equity-Backed | New York, NY |
NowRx Signals
NowRx Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Checkmate Capital | Venture Capital | Minority | ||
| Decathlon Capital Partners | Growth/Expansion | Minority | ||
| HealthCo Ventures | Venture Capital | Minority | ||
| Milkbox Partners | Venture Capital | Minority | ||
| Gershon Capital | Venture Capital | Minority |
NowRx FAQs
-
When was NowRx founded?
NowRx was founded in 2015.
-
Where is NowRx headquartered?
NowRx is headquartered in Laguna Niguel, CA.
-
What is the size of NowRx?
NowRx has 79 total employees.
-
What industry is NowRx in?
NowRx’s primary industry is Drug Delivery.
-
Is NowRx a private or public company?
NowRx is a Private company.
-
What is NowRx’s current revenue?
The current revenue for NowRx is .
-
How much funding has NowRx raised over time?
NowRx has raised $65.1M.
-
Who are NowRx’s investors?
Checkmate Capital, Decathlon Capital Partners, HealthCo Ventures, Milkbox Partners, and Gershon Capital are 5 of 12 investors who have invested in NowRx.
-
Who are NowRx’s competitors?
PillPack, Practo, Alto Pharmacy, and Blink Health are competitors of NowRx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process